Novo Nordisk (NVO) US Chief says twice as many medicare patients prefer GLP-1 pill to shot; seeking bolt-on M&A to boost portfolio

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

BoC MInutes: Agreed that monetary policy will need to remain nimble

ECB's Zigman says main goal is price stability

Novo Nordisk (NVO) US Chief says twice as many medicare patients prefer GLP-1 pill to shot; seeking bolt-on M&A to boost portfolio

US President Trump says Iran is making big concessions and its going very well

US sells USD 70bln of 5yr notes; tails 0.7bps

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Related headlines

The feed had this first.

Use the Platform